NO932874L - Anvendelse av lacidipin for behandling av arteriosklerose - Google Patents

Anvendelse av lacidipin for behandling av arteriosklerose

Info

Publication number
NO932874L
NO932874L NO93932874A NO932874A NO932874L NO 932874 L NO932874 L NO 932874L NO 93932874 A NO93932874 A NO 93932874A NO 932874 A NO932874 A NO 932874A NO 932874 L NO932874 L NO 932874L
Authority
NO
Norway
Prior art keywords
treatment
scerosis
arteryos
lacidipin
application
Prior art date
Application number
NO93932874A
Other languages
English (en)
Other versions
NO303713B1 (no
NO932874D0 (no
Inventor
Giovanni Gaviraghi
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of NO932874D0 publication Critical patent/NO932874D0/no
Publication of NO932874L publication Critical patent/NO932874L/no
Publication of NO303713B1 publication Critical patent/NO303713B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO932874A 1991-02-13 1993-08-12 Anvendelse av lacidipin for behandling av arteriosklerose NO303713B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici
PCT/EP1992/000276 WO1992014460A1 (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis

Publications (3)

Publication Number Publication Date
NO932874D0 NO932874D0 (no) 1993-08-12
NO932874L true NO932874L (no) 1993-08-12
NO303713B1 NO303713B1 (no) 1998-08-24

Family

ID=11358541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932874A NO303713B1 (no) 1991-02-13 1993-08-12 Anvendelse av lacidipin for behandling av arteriosklerose

Country Status (23)

Country Link
US (1) US5455257A (no)
EP (2) EP0576433A1 (no)
JP (1) JP2996725B2 (no)
KR (1) KR100188171B1 (no)
AT (1) ATE157004T1 (no)
AU (1) AU646929B2 (no)
CA (1) CA2103805C (no)
CZ (1) CZ281760B6 (no)
DE (1) DE69221649T2 (no)
DK (1) DK0499920T3 (no)
ES (1) ES2106098T3 (no)
GR (1) GR3024661T3 (no)
IE (1) IE920453A1 (no)
IL (1) IL100928A (no)
IT (1) IT1244728B (no)
MX (1) MX9200600A (no)
NO (1) NO303713B1 (no)
PH (1) PH30130A (no)
RU (1) RU2136279C1 (no)
SG (1) SG59972A1 (no)
UA (1) UA27780C2 (no)
WO (1) WO1992014460A1 (no)
ZA (1) ZA921006B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0809505T3 (da) * 1995-06-07 2003-07-07 Ivax Research Inc Anvendelse af pentosanpolysulfat til resolution af ar ved kroniske progressive vaskulære sygdomme
RU2287327C2 (ru) * 2003-10-16 2006-11-20 Юрий Антонович Кошелев Средство для лечения и профилактики атеросклероза
WO2006113309A1 (en) * 2005-04-15 2006-10-26 Dr. Reddy's Laboratories Ltd. Lacidipine particles
WO2007096694A1 (es) * 2006-02-22 2007-08-30 Ramiro Vergara Asociacion de principios activos neuroactivadores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition

Also Published As

Publication number Publication date
DE69221649T2 (de) 1997-12-11
JP2996725B2 (ja) 2000-01-11
HK1009585A1 (en) 1999-06-04
NO303713B1 (no) 1998-08-24
IE920453A1 (en) 1992-08-12
ITMI910359A1 (it) 1992-08-13
EP0499920B1 (en) 1997-08-20
ITMI910359A0 (it) 1991-02-13
NO932874D0 (no) 1993-08-12
PH30130A (en) 1997-01-21
GR3024661T3 (en) 1997-12-31
ATE157004T1 (de) 1997-09-15
CZ281760B6 (cs) 1997-01-15
US5455257A (en) 1995-10-03
SG59972A1 (en) 1999-02-22
IT1244728B (it) 1994-08-08
WO1992014460A1 (en) 1992-09-03
AU1223192A (en) 1992-09-15
ES2106098T3 (es) 1997-11-01
KR100188171B1 (en) 1999-06-01
UA27780C2 (uk) 2000-10-16
MX9200600A (es) 1992-10-30
EP0576433A1 (en) 1994-01-05
CA2103805A1 (en) 1992-08-14
RU2136279C1 (ru) 1999-09-10
EP0499920A1 (en) 1992-08-26
ZA921006B (en) 1992-12-30
CZ165093A3 (en) 1994-03-16
AU646929B2 (en) 1994-03-10
DE69221649D1 (de) 1997-09-25
DK0499920T3 (da) 1998-01-26
CA2103805C (en) 2002-09-17
IL100928A (en) 1997-02-18
JPH06505002A (ja) 1994-06-09

Similar Documents

Publication Publication Date Title
DE69620306D1 (de) 4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege
DK0393911T3 (da) Fungicide oxazolidinoner
ATE253361T1 (de) Mittel zur gesteuerten freisetzung von paroxetin
ATE121295T1 (de) Augentropfenarzneimittel.
DE69300062D1 (de) Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
FI964566L (fi) Menetelmä ja diastereomeerisia suoloja, jotka ovat käyttökelpoisia raseemisen alfa-(4-(1,1-dimetyletyl)fenyl)-4-(hydroksidifenyyli-metyyli)-1-piperidiinibutanolin ja sen johdosyhdisteiden optisessa resoluutiossa
NO932874D0 (no) Anvendelse av lacidipin for behandling av arteriosklerose
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
RU93054780A (ru) Применение лацидипина для лечения артериосклероза
EE04235B1 (et) Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks
DE69231883D1 (de) 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
DE59310153D1 (de) Verfahren zur Herstellung von 4-Hydroxy-2.2.6.6-tetramethylpiperidin
DE69625069D1 (de) Insektizide von n-(substituiertes arylmethyl)-4-(bis (substituiertes phenyl oder pyridyl)methyl)-piperidin.
NO953322D0 (no) Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler
ITRM910211A0 (it) Impianto dentale endosseo.
ATE122352T1 (de) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
NO924767L (no) Anordning for bedring av miljö i munnhulen ved tannbehandling
EP0800393A4 (en) MONOMERS OF 4.4- (DISUBSTITUTED) CYCLOHEXAN-1-ONE AND COMPOUNDS THEREOF
DZ1831A1 (fr) Isopropyl 2-méthoxyéthyl 4-(2-chloro-3-cyano-phényl)-1,4-dihydro 2,6-diméthyl-pyridine 3,5-dicarboxylate.
NO985558D0 (no) Ny forbedret formulering for behandling av tromboembolisme
DE69616484D1 (de) Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als Arzneimittel
EP0799183A4 (en) MONOMERS OF 3.3- (DISUBSTITUTED) CYCLOHEXAN-1-ONE AND RELATED COMPOUNDS
DE69200943D1 (de) Derivate von Piperidin.
ES1023915Y (es) Implante dental.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees